• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白藜芦醇通过作用于细胞膜蛋白PLA2增强顺铂的抗肝癌作用。

Resveratrol enhances the antiliver cancer effect of cisplatin by targeting the cell membrane protein PLA2.

作者信息

Gao Yu, Yang Zhanyi, Bajpai Akhilesh Kumar, Wang Wenben, Zhang Liyuan, Xia Zhenhong

机构信息

Department of Pharmacy, Binzhou Medical University, Yantai, China.

Department of Genetics, Genomics and Informatics, University of Tennessee Health Science Center, Memphis, TN, United States.

出版信息

Front Oncol. 2024 Sep 24;14:1453164. doi: 10.3389/fonc.2024.1453164. eCollection 2024.

DOI:10.3389/fonc.2024.1453164
PMID:39381045
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11458693/
Abstract

BACKGROUND

In this study, we aimed to explore the mechanism by which resveratrol promotes cisplatin-induced death of HepG2 cells and to provide a potential strategy for resveratrol in the treatment of cancer.

METHODS

HepG2 cells were exposed to a range of drug concentrations for 24 h: resveratrol (2.5 μg/mL [10.95 μM], 5 μg/mL [21.91 μM], 10 μg/mL [43.81 μM], 20 μg/mL [87.62 μM], 40 μg/mL [175.25 μM], and 80 μg/mL [350.50 μM]), cisplatin (0.625 μg/mL [2.08 μM], 1.25 μg/mL [4.17 μM], 2.5 μg/mL [8.33 μM], 4.5 μg/mL [15.00 μM], and 10 μg/mL [33.33 μM]), 24 μg/mL (105.15 μM) resveratrol + 9 μg/mL (30.00 μM) cisplatin, and 12 μg/mL (52.57 μM) resveratrol + 4.5 μg/mL (15.00 μM) cisplatin. The interaction of two drugs was evaluated by coefficient of drug interaction (CDI), which was based on the Pharmacological Additivity model. The MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay was used to detect the effect of different concentrations of drugs on cell viability, while transcriptome sequencing was used to identify pathways associated with higher gene enrichment. Synchrotron radiation FTIR microspectroscopy experiments and data analysis were conducted to obtain detailed spectral information. The second-derivative spectra were calculated using the Savitzky-Golay algorithm. Single-cell infrared spectral absorption matrices were constructed to analyze the spectral characteristics of individual cells. The Euclidean distance between cells was calculated to assess their spectral similarity. The cell-to-cell Euclidean distance was computed to evaluate the spatial relationships between cells. The target protein of resveratrol was verified by performing a Western blot analysis.

RESULTS

After 24 h of treatment with resveratrol, HepG2 cell growth was inhibited in a dose-dependent manner. Resveratrol promotes cisplatin-induced HepG2 cell death through membrane-related pathways. It also significantly changes the membrane components of HepG2 cells. Additionally, resveratrol changes the morphology of the HepG2 cell membrane by decreasing the expression of PLA2G2.

CONCLUSION

Resveratrol changes the morphology of the HepG2 cell membrane by decreasing the expression of PLA2G2 and promotes cisplatin-induced HepG2 cell death. The combination of cisplatin and resveratrol can play a synergistic therapeutic effect on HepG2 cells.

摘要

背景

在本研究中,我们旨在探究白藜芦醇促进顺铂诱导的HepG2细胞死亡的机制,并为白藜芦醇在癌症治疗中提供潜在策略。

方法

将HepG2细胞暴露于一系列药物浓度下24小时:白藜芦醇(2.5μg/mL [10.95μM]、5μg/mL [21.91μM]、10μg/mL [43.81μM]、20μg/mL [87.62μM]、40μg/mL [175.25μM]和80μg/mL [350.50μM])、顺铂(0.625μg/mL [2.08μM]、1.25μg/mL [4.17μM]、2.5μg/mL [8.33μM]、4.5μg/mL [15.00μM]和10μg/mL [33.33μM])、24μg/mL(105.15μM)白藜芦醇+9μg/mL(30.00μM)顺铂以及12μg/mL(52.57μM)白藜芦醇+4.5μg/mL(15.00μM)顺铂。基于药理相加模型,通过药物相互作用系数(CDI)评估两种药物的相互作用。采用MTT 3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四氮唑溴盐法检测不同浓度药物对细胞活力的影响,同时利用转录组测序鉴定与基因富集程度较高相关的通路。进行同步辐射傅里叶变换红外光谱显微实验及数据分析以获取详细光谱信息。使用Savitzky-Golay算法计算二阶导数光谱。构建单细胞红外光谱吸收矩阵以分析单个细胞的光谱特征。计算细胞间的欧几里得距离以评估其光谱相似性。计算细胞到细胞的欧几里得距离以评估细胞间的空间关系。通过蛋白质免疫印迹分析验证白藜芦醇的靶蛋白。

结果

用白藜芦醇处理24小时后,HepG2细胞生长受到剂量依赖性抑制。白藜芦醇通过膜相关途径促进顺铂诱导的HepG2细胞死亡。它还显著改变HepG2细胞的膜成分。此外,白藜芦醇通过降低PLA2G2的表达改变HepG2细胞膜的形态。

结论

白藜芦醇通过降低PLA2G2的表达改变HepG2细胞膜的形态,并促进顺铂诱导的HepG2细胞死亡。顺铂与白藜芦醇联合应用可对HepG2细胞发挥协同治疗作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5abd/11458693/24482c6a17c7/fonc-14-1453164-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5abd/11458693/fad7c97aff4b/fonc-14-1453164-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5abd/11458693/5bbd91a326a4/fonc-14-1453164-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5abd/11458693/c6efb2ab4f02/fonc-14-1453164-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5abd/11458693/24482c6a17c7/fonc-14-1453164-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5abd/11458693/fad7c97aff4b/fonc-14-1453164-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5abd/11458693/5bbd91a326a4/fonc-14-1453164-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5abd/11458693/c6efb2ab4f02/fonc-14-1453164-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5abd/11458693/24482c6a17c7/fonc-14-1453164-g004.jpg

相似文献

1
Resveratrol enhances the antiliver cancer effect of cisplatin by targeting the cell membrane protein PLA2.白藜芦醇通过作用于细胞膜蛋白PLA2增强顺铂的抗肝癌作用。
Front Oncol. 2024 Sep 24;14:1453164. doi: 10.3389/fonc.2024.1453164. eCollection 2024.
2
Resveratrol enhances anticancer effects of paclitaxel in HepG2 human liver cancer cells.白藜芦醇增强紫杉醇对 HepG2 人肝癌细胞的抗癌作用。
BMC Complement Altern Med. 2017 Oct 4;17(1):477. doi: 10.1186/s12906-017-1956-0.
3
[Resveratrol induces HepG2 cell apoptosis by depolarizing mitochondrial membrane].白藜芦醇通过使线粒体膜去极化诱导肝癌细胞系HepG2细胞凋亡
Nan Fang Yi Ke Da Xue Xue Bao. 2006 Apr;26(4):406-8, 413.
4
Synergistic anti-proliferative effect of resveratrol and etoposide on human hepatocellular and colon cancer cell lines.白藜芦醇与依托泊苷对人肝癌和结肠癌细胞系的协同抗增殖作用。
Eur J Pharmacol. 2013 Oct 15;718(1-3):34-40. doi: 10.1016/j.ejphar.2013.09.020. Epub 2013 Sep 17.
5
Melatonin attenuates cisplatin-induced HepG2 cell death via the regulation of mTOR and ERCC1 expressions.褪黑素通过调节mTOR和ERCC1的表达减轻顺铂诱导的HepG2细胞死亡。
World J Hepatol. 2014 Apr 27;6(4):230-42. doi: 10.4254/wjh.v6.i4.230.
6
Resveratrol Enhances Anticancer Effects of Silybin on HepG2 Cells and H22 Tumor-bearing Mice via Inducing G2/M Phase Arrest and Increasing Bax/Bcl-2 Ratio.白藜芦醇通过诱导G2/M期阻滞和增加Bax/Bcl-2比值增强水飞蓟宾对HepG2细胞和H22荷瘤小鼠的抗癌作用。
Comb Chem High Throughput Screen. 2025;28(1):89-98. doi: 10.2174/0113862073263408231101105647.
7
Kanglaite enhances the efficacy of cisplatin in suppression of hepatocellular carcinoma via inhibiting CKLF1 mediated NF-κB pathway and regulating transporter mediated drug efflux.康莱特增强顺铂抑制肝癌的疗效通过抑制 CKLF1 介导的 NF-κB 通路和调节转运体介导的药物外排。
J Ethnopharmacol. 2021 Jan 10;264:113388. doi: 10.1016/j.jep.2020.113388. Epub 2020 Sep 10.
8
Genotoxic potential of selected cytostatic drugs in human and zebrafish cells.所选细胞毒性药物在人和斑马鱼细胞中的遗传毒性潜力。
Environ Sci Pollut Res Int. 2016 Aug;23(15):14739-50. doi: 10.1007/s11356-015-4592-6. Epub 2015 May 7.
9
Evaluation of Cytotoxic Potential of Extracts on Human Hepatocarcinoma HepG2 and Normal HEK293T Cell Lines.评价 提取物对人肝癌 HepG2 细胞和正常 HEK293T 细胞系的细胞毒性。
Biomed Res Int. 2022 Sep 22;2022:1279961. doi: 10.1155/2022/1279961. eCollection 2022.
10
Resveratrol inhibits cisplatin-induced epithelial-to-mesenchymal transition in ovarian cancer cell lines.白藜芦醇抑制顺铂诱导的卵巢癌细胞系上皮-间质转化。
PLoS One. 2014 Jan 22;9(1):e86987. doi: 10.1371/journal.pone.0086987. eCollection 2014.

本文引用的文献

1
Does resveratrol reduce cisplatin-induced ovarian damage?白藜芦醇能否减轻顺铂诱导的卵巢损伤?
Rev Assoc Med Bras (1992). 2023 Aug 14;69(8):e20230314. doi: 10.1590/1806-9282.20230314. eCollection 2023.
2
Cisplatin in Liver Cancer Therapy.顺铂在肝癌治疗中的应用。
Int J Mol Sci. 2023 Jun 29;24(13):10858. doi: 10.3390/ijms241310858.
3
Combination therapy of cisplatin and resveratrol to induce cellular aging in gastric cancer cells: Focusing on oxidative stress, and cell cycle arrest.顺铂与白藜芦醇联合治疗诱导胃癌细胞衰老:聚焦于氧化应激和细胞周期阻滞
Front Pharmacol. 2023 Jan 4;13:1068863. doi: 10.3389/fphar.2022.1068863. eCollection 2022.
4
Hepatocellular Carcinoma: New Developments.肝细胞癌:新进展。
Clin Liver Dis. 2023 Feb;27(1):85-102. doi: 10.1016/j.cld.2022.08.004. Epub 2022 Oct 18.
5
Evaluation of synergism in drug combinations and reference models for future orientations in oncology.肿瘤学中药物联合的协同作用评估及未来方向的参考模型
Curr Res Pharmacol Drug Discov. 2022 May 12;3:100110. doi: 10.1016/j.crphar.2022.100110. eCollection 2022.
6
Human organoids in basic research and clinical applications.人类器官类器官在基础研究和临床应用中的应用。
Signal Transduct Target Ther. 2022 May 24;7(1):168. doi: 10.1038/s41392-022-01024-9.
7
Potential Therapeutic Targets of Resveratrol, a Plant Polyphenol, and Its Role in the Therapy of Various Types of Cancer.白藜芦醇作为一种植物多酚的潜在治疗靶点及其在各种类型癌症治疗中的作用。
Molecules. 2022 Apr 21;27(9):2665. doi: 10.3390/molecules27092665.
8
Effect of resveratrol on drug resistance in colon cancer chemotherapy.白藜芦醇对结肠癌化疗耐药性的影响。
RSC Adv. 2019 Jan 18;9(5):2572-2580. doi: 10.1039/c8ra08364a.
9
The Potential of Metabolism-Related Gene OGDHL as a Biomarker for Myocardial Remodeling in Dilated Cardiomyopathy.代谢相关基因OGDHL作为扩张型心肌病心肌重构生物标志物的潜力
Front Cardiovasc Med. 2022 Apr 7;9:741920. doi: 10.3389/fcvm.2022.741920. eCollection 2022.
10
Metformin inhibits the tumor-promoting effect of low-dose resveratrol, and enhances the anti-tumor activity of high-dose resveratrol by increasing its reducibility in triple negative breast cancer.二甲双胍通过增加三阴性乳腺癌中白藜芦醇的还原能力来抑制低剂量白藜芦醇的促肿瘤作用,并增强高剂量白藜芦醇的抗肿瘤活性。
Free Radic Biol Med. 2022 Feb 20;180:108-120. doi: 10.1016/j.freeradbiomed.2022.01.010. Epub 2022 Jan 14.